Literature DB >> 12743233

Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment.

K Marder1, S M Albert, M P McDermott, J C McArthur, G Schifitto, O A Selnes, N Sacktor, Y Stern, D Palumbo, K Kieburtz, B Cohen, C Orme, L G Epstein.   

Abstract

OBJECTIVE: To determine the inter-rater reliability of a modification of the Memorial Sloan-Kettering (MSK) Staging for HIV-associated cognitive impairment.
METHODS: Data were abstracted on neurologic, neuropsychological, and functional status on 100 individuals participating at four sites in the Northeast AIDS Dementia (NEAD) Consortium cohort study, a longitudinal study of predictors of cognitive impairment in HIV-infected individuals. Neuropsychological performance was defined 1) based on the neuropsychologist's global impression and 2) solely based on neuropsychological test scores. Raters at each site used the abstracted data to assign an MSK stage to each subject blind to any identifying information. Inter-rater reliability was assessed using kappa statistics. Agreement between computer-generated ratings and site-generated ratings was also assessed.
RESULTS: Kappa statistics for pair-wise agreement among the sites regarding MSK stage ranged from 0.70-0.91, representing good to excellent agreement between sites. Agreement between computer-generated ratings and site-generated ratings was in the good to excellent range (0.62-0.79).
CONCLUSIONS: The authors have modified the MSK rating scale and developed a reliable instrument that can be used in multicenter studies. This instrument will be useful in staging HIV-dementia in future longitudinal studies and will be valuable in increasing accuracy of clinicopathologic studies.

Entities:  

Mesh:

Year:  2003        PMID: 12743233     DOI: 10.1212/01.wnl.0000064172.46685.82

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Authors:  Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; George Hana; Uraina Clark; Assawin Gongvatana; Robert Paul; Michael Taylor; Paul Thompson; Jeffery Alger; Mark Brown; Jianhui Zhong; Thomas Campbell; Elyse Singer; Eric Daar; Deborah McMahon; Yuen Tso; Constantin T Yiannoutsos; Bradford Navia
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

Review 3.  Technology-Mediated Interventions and Quality of Life for Persons Living with HIV/AIDS. A Systematic Review.

Authors:  Hwayoung Cho; Sarah Iribarren; Rebecca Schnall
Journal:  Appl Clin Inform       Date:  2017-04-12       Impact factor: 2.342

4.  Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Authors:  Yisel Cantres-Rosario; Marines Plaud-Valentín; Yamil Gerena; Richard L Skolasky; Valerie Wojna; Loyda M Meléndez
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

5.  Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology.

Authors:  Saori Shimizu; Muhammad Z Khan; Randi L Hippensteel; Anjum Parkar; Ramesh Raghupathi; Olimpia Meucci
Journal:  Neurobiol Dis       Date:  2006-09-28       Impact factor: 5.996

6.  Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV.

Authors:  Jennifer M Coughlin; Yuchuan Wang; Shuangchao Ma; Chen Yue; Pearl K Kim; Ashley V Adams; Heidi V Roosa; Kenneth L Gage; Marigo Stathis; Rana Rais; Camilo Rojas; Jennifer L McGlothan; Crystal C Watkins; Ned Sacktor; Tomas R Guilarte; Yun Zhou; Akira Sawa; Barbara S Slusher; Brian Caffo; Michael Kassiou; Christopher J Endres; Martin G Pomper
Journal:  J Neurovirol       Date:  2014-02-25       Impact factor: 2.643

Review 7.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

8.  Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans.

Authors:  Dinesh Singh; John A Joska; Karl Goodkin; Enrique Lopez; Landon Myer; Robert H Paul; Sally John; Henry Sunpath
Journal:  BMC Res Notes       Date:  2010-01-29

9.  Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.

Authors:  Noeline Nakasujja; Richard L Skolasky; Seggane Musisi; Peter Allebeck; Kevin Robertson; Allan Ronald; Elly Katabira; David B Clifford; Ned Sacktor
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

10.  Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients.

Authors:  Beau M Ances; Anne C Roc; Marc Korczykowski; Ronald L Wolf; Dennis L Kolson
Journal:  J Neurovirol       Date:  2008-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.